Aptevo Therapeutics Inc. (APVO) Insider Trading Disclosures
Aptevo Therapeutics Inc. (APVO) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: APVO
CIK: 1671584
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Baker Tilly US, LLP
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerJeremy Kuhlmann
Audit LocationSeattle, Washington, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-14 | 2026-10-14 | 8-K | 0001193125-26-421076 | View SEC Doc Filr Page |
| S-8 | 2026-09-25 | — | S-8 | 0001193125-26-402813 | View SEC Doc Filr Page |
| 8-K | 2026-09-24 | 2026-09-24 | 8-K | 0001193125-26-400213 | View SEC Doc Filr Page |
| 8-K | 2026-09-23 | 2026-09-22 | 8-K | 0001193125-26-399545 | View SEC Doc Filr Page |
| 424B4 | 2026-09-03 | — | 424B4 | 0001193125-26-381149 | View SEC Doc Filr Page |
| 8-K | 2026-09-03 | 2026-09-03 | 8-K | 0001193125-26-381098 | View SEC Doc Filr Page |
| EFFECT | 2026-09-02 | — | EFFECT Filing | 9999999995-26-002871 | View SEC Doc Filr Page |
| DEF 14A | 2026-08-31 | 2026-09-22 | DEF 14A | 0001193125-26-376763 | View SEC Doc Filr Page |
| CORRESP | 2026-08-31 | — | CORRESP Filing | 0001193125-26-377083 | View SEC Doc Filr Page |
| UPLOAD | 2026-08-27 | — | UPLOAD Filing | 0000000000-26-008467 | View SEC Doc Filr Page |
| D | 2026-08-26 | — | D Filing | 0001193125-26-368286 | View SEC Doc Filr Page |
| PRE 14A | 2026-08-21 | 2026-08-21 | PRE 14A | 0001193125-26-361119 | View SEC Doc Filr Page |
| S-1 | 2026-08-21 | — | S-1 | 0001193125-26-361103 | View SEC Doc Filr Page |
| 8-K | 2026-08-21 | 2026-08-21 | 8-K | 0001193125-26-361079 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001649553-26-000098 | View SEC Doc Filr Page |
| 10-Q | 2026-08-14 | 2026-06-30 | 10-Q | 0001193125-26-350559 | View SEC Doc Filr Page |
| 8-K | 2026-08-14 | 2026-08-14 | 8-K | 0001193125-26-350537 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-12 | 8-K | 0001193125-26-349380 | View SEC Doc Filr Page |
| 4 | 2026-08-10 | 2026-08-06 | 4 | 0001193125-26-343080 | View SEC Doc Filr Page |
| 4 | 2026-08-10 | 2026-08-06 | 4 | 0001193125-26-343079 | View SEC Doc Filr Page |
| 4 | 2026-08-10 | 2026-08-06 | 4 | 0001193125-26-343077 | View SEC Doc Filr Page |
| 4 | 2026-08-10 | 2026-08-06 | 4 | 0001193125-26-343076 | View SEC Doc Filr Page |
| 4 | 2026-08-10 | 2026-08-06 | 4 | 0001193125-26-343073 | View SEC Doc Filr Page |
| 4 | 2026-08-10 | 2026-08-06 | 4 | 0001193125-26-343072 | View SEC Doc Filr Page |
| 4 | 2026-08-10 | 2026-07-17 | 4 | 0001193125-26-343070 | View SEC Doc Filr Page |